LEIFRAS LFS Slips 481 Testing 169 Support 20260520 Ovid Therapeutics OVID Drops 167 Key Support at 224 20260520 Genpacts Tyagarajan Warns of AIDriven Reduction in IT Workload and Jobs USChina Summit Yields Soybean and Rare Earth Deals as Tariff Cuts Remain Uncertain Replimune Group REPL Q1 2026 Earnings Beat Revenue NA EPS 077 Grasim Industries Q4 Results Standalone Net Loss Narrows to 163 Crore Revenue Surges 32 Declares 10 Dividend Berkshire Hathaway Shakes Up Portfolio Major Stake in Delta Airlines and Hefty Increase in Alphabet Holdings